FearLess in NeuroOncology

Part of paid clinical trials in Richmond, Virginia.

Sponsor
Virginia Commonwealth University
Study ID
NCT06989086
Status
Recruiting
Apply to this trial

Conditions

  • Astrocytoma
  • Caregiver
  • Glioblastoma (GBM)
  • Oligodendroglioma
  • Primary Malignant Brain Tumor

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Fearless in Neuro-Oncology — BEHAVIORAL
    FearLess is a newly developed, empirically-rooted, manualized psychological intervention consisting of an intake + 8 sessions delivered over a 12-week time period. It consists of weekly individual 60- to 90-minute virtual therapy sessions.

Study Details

The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers

Key Dates

Start date
Jun 24, 2025
Status verified
Sep 2025
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
112 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Fearless Immediate Treatment Arm
    FearLess is a newly developed, empirically-rooted, manualized psychological intervention consisting of an intake + 8 sessions delivered over a 12-week time period. It consists of weekly individual 60- to 90-minute virtual therapy sessions. FearLess will be delivered immediately following enrollment in this arm.
  • Other: FearLess Delayed Control Arm
    FearLess is a newly developed, empirically-rooted, manualized psychological intervention consisting of an intake + 8 sessions delivered over a 12-week time period. It consists of weekly individual 60- to 90-minute virtual therapy sessions. In this arm, the FearLess intervention will begin following a 12-week no-treatment period.

Primary Outcome Measure

Feasibility - Study Enrollment [ Time Frame: From screening to randomization allocation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Virginia Commonwealth UniversityRichmondVirginia23298
Ashlee Loughan, PhD
[email protected]

Find similar trials in Richmond, VA

By condition
Brain cancer
By specialty
OncologyNeuro-oncology
By research site
Virginia Commonwealth University· Richmond, VA

Related Studies